18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum ; day:28 ; month:9 ; year:2021 ; pages:1-12
European journal of nuclear medicine and molecular imaging ; (28.9.2021), 1-12
- Creator
-
Moscoso, Alexis
Silva-Rodríguez, Jesús
Aldrey, Jose Manuel
Cortés, Julia
Pías-Peleteiro, Juan Manuel
Ruibal, Álvaro
Aguiar, Pablo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-021-05493-y
- URN
-
urn:nbn:de:101:1-2021121806283347802149
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moscoso, Alexis
- Silva-Rodríguez, Jesús
- Aldrey, Jose Manuel
- Cortés, Julia
- Pías-Peleteiro, Juan Manuel
- Ruibal, Álvaro
- Aguiar, Pablo
- SpringerLink (Online service)
Other Objects (12)
Myelin in Alzheimer’s disease: culprit or bystander?
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Changes of Myelin Organization in Patients with Alzheimer’s Disease Shown by q-Space Myelin Map Imaging
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease
White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes
Effects of non-modifiable risk factors of Alzheimer’s disease on intracortical myelin content
Ageing-associated myelin dysfunction as a driver of amyloid deposition in Alzheimer’s disease
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
Attitudes toward clinical trials across the Alzheimer’s disease spectrum
Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease
Myelin in Alzheimer’s disease: culprit or bystander?
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Changes of Myelin Organization in Patients with Alzheimer’s Disease Shown by q-Space Myelin Map Imaging
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease
White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes
Effects of non-modifiable risk factors of Alzheimer’s disease on intracortical myelin content
Ageing-associated myelin dysfunction as a driver of amyloid deposition in Alzheimer’s disease
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
Attitudes toward clinical trials across the Alzheimer’s disease spectrum
Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease
Myelin in Alzheimer’s disease: culprit or bystander?
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Changes of Myelin Organization in Patients with Alzheimer’s Disease Shown by q-Space Myelin Map Imaging
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease
White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes
Effects of non-modifiable risk factors of Alzheimer’s disease on intracortical myelin content
Ageing-associated myelin dysfunction as a driver of amyloid deposition in Alzheimer’s disease
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
Attitudes toward clinical trials across the Alzheimer’s disease spectrum